Fonte: Memórias do Instituto Oswaldo Cruz. Unidades: ICB, FCF
Assuntos: PLASMODIUM, VACINAS, ADJUVANTES IMUNOLÓGICOS
ABNT
BARGIERI, Daniel Youssef et al. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, v. 102, n. 3, p. 313-317, 2007Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762007005000039. Acesso em: 14 nov. 2024.APA
Bargieri, D. Y., Rosa, D. S., Lasaro, M. A. S., Ferreira, L. C. de S., Soares, I. da S., & Rodrigues, M. M. (2007). Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, 102( 3), 313-317. doi:10.1590/s0074-02762007005000039NLM
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0074-02762007005000039Vancouver
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1590/s0074-02762007005000039